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Background: Higher HIV prevalence is commonly observed among migrant population in sub-
Saharan Africa, however the extent to which migration is a cause or consequence of HIV infection 
is largely unknown. Here, we use population-based, longitudinal survey data and assess HIV 
incidence among men and women migrating into communities in Rakai District, Uganda.  
Methodology: Prospective data from HIV-negative participants residing in thirty communities 
under continuous surveillance in the Rakai Community Cohort Study (RCCS) between 1999 and 
2016 was used to assess the association between recent migration and HIV incidence. The RCCS 
is an open population-based census and cohort of adults aged 15-49 in rural southcentral Uganda. 
Recent in-migrants were classified as individuals who moved to a new community within the last 
two years with intention to stay and were identified through census. Newly HIV-positive 
individuals were considered incident HIV cases if they had an HIV negative test result at the prior 
survey allowing for one missed visit. Poisson regression with generalized estimating equations and 
robust variance estimators were used to estimate the incidence rate ratios (IRR) of HIV infection 
associated with recent migration for men and women visits with adjustment for demographics, 
sexual risk behaviors, and calendar time.  
Results: The association between HIV incidence and recent migration was assessed among 16,165 
HIV-negative individuals of which 55% (n=8,789) were women and 28% (n=4529) were classified 
as recent migrants. Participants contributed 69,231 person-visits at which 851 incident HIV events 
were identified (n=357 in men; n=492 in women). Compared to long-term residents, risk of HIV-
infection was statistically significantly elevated among migrant women relative to long-term 
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residents before and after adjustment for potential confounders (IRR=2.10, 95%CI:1.62-2.73; 
adjIRR=1.81, 95%CI: 1.37-2.41). Similar risk of HIV with migration was found among men  
(IRR=1.82, 95%CI: 1.17-2.86); adjIRR=1.80, 95%CI: 1.14-2.82). We found no significant 
differences in the association between migration and HIV by calendar time in our analyses.  
Conclusion: Our Data suggests that the earliest years after migration is associated with increased 
risk of HIV acquisition in men and women. These findings highlight the need for timely 
interventions targeted to migrant population to reduce HIV incidence in sub-Saharan Africa. 
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In Sub-Saharan Africa, migrants have higher HIV prevalence than individuals with no migration 
history. However, the pathway through which migration is associated is not clear. Individuals who 
move may be more likely to be HIV positive or the migration process itself may increase HIV risk.  
This thesis focuses on the of HIV infection following in-migration into 30 communities in rural 
Rakai, Uganda. Rakai, bordered by Lake Victoria to the East and Tanzania to the South, was the 
initial epicenter of the HIV epidemic in Eastern Africa.  
Specifically, we use data collected between April 1999 and January 2016 from the Rakai 
Community Cohort study (RCCS) for this study. The RCCS is an ongoing longitudinal study of 
HIV incidence, sexual behaviors, and health service utilization in the Rakai District, Uganda. Here, 
we used RCCS census data to identify in-migrants and their time since arrival in RCCS study 
communities. We then compared HIV incidence between long-term residents with no migration 
history and in-migrants at varying times since in-migration to their new community. 
1.1. Epidemiology of HIV/AIDS in Sub-Saharan Africa  
 
More than 35 million people have died from AIDS related illness since the beginning of the 
epidemic more than thirty years ago.1Although progress has been made since the discovery of 
highly active antiretroviral therapy (ART) in 1996, the number of people living with the infection 
remains high.1,2 In 2015, 2.1 million people were newly infected with the virus, bringing the number 
of people living with the infection globally to 36.7 million. Sub-Saharan Africa (SSA) bears a 
disproportionate burden of HIV cases. Although HIV prevalence has declined in some locations, 
the regions still accounts for 66% of people living with HIV and nearly 80% of AIDS-related 
deaths.1,2 
Although HIV was first recognized amongst mobile and commercial sex workers in the 
Central and Eastern region,3,4 the African epidemic is generalized affecting  virtually all members 
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of the society.5 The predominant mode of HIV transmission is through heterosexual sexual 
intercourse,5 however men who have sex with men (MSM) and injection drug users (IDU) are 
increasingly being recognized as key populations at risk in the region.6-8  
Adolescent girls and women are at highest risk of HIV acquisition in sub-Saharan Africa; 
women account for 52% of all people living with HIV in SSA.1,9Young women aged 15-24 are 
particularly at risk.10 In some countries in SSA the prevalence of HIV in young women is two to 
eight times the prevalence in young men of the same age.11,12  For example, a study carried out in 
Kenya and Zambia found prevalence was six and 3 times higher in sexually active 15-19-year-old 
and 20-24-year-old women respectively compared to sexually active men of the same 
age.10,12Reasons for gender disparities in HIV burden remain unclear however, biological 
differences in HIV transmission,13 gender based violence, gender inequalities, poor access to 
education, reproductive, and sexual health services and poverty are presumed to be among the main 
drivers for increased female HIV risk observed in women in SSA.1,9 
There are substantial heterogeneities in prevalence and risk factors for HIV throughout Sub-
Saharan Africa. The countries in the southern and eastern region are the most affected with 
countries in Southern Africa having the greatest prevalence.1,9 Swaziland, a country in Southern 
Africa has the highest burden of HIV in the world with a prevalence of 26.5%.9,14 Lesotho and 
Botswana, also in the southern region of SSA have a prevalence of 23.1% and 23% respectively.9,14 
The burden of HIV in SSA is lowest in western countries where prevalence is estimated to be about 
2%5,9 with Nigeria being the most affected country in the region (3.1%).9,14 Prevalence in the 
Eastern Africa is estimated to range from 2.9% to 7.9%.9,14 The prevalence in Central Africa lies 
between levels in Eastern and Western Africa with estimates ranging from 1.1% in Democratic 
republic of The Congo to 3.1% Cameroon.9,14 
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1.2. Treatment and Prevention of HIV 
 
Since the onset of the HIV epidemic, various treatment and prevention interventions have been 
put in place to limit the spread of the epidemic. Combined HIV prevention (CHP) strategies are 
being used to control the HIV epidemic.15  CHP involves the implementation of multiple prevention 
interventions including antiretroviral therapy (ART), voluntary medical male circumcision 
(VMMC) and behavioral interventions to reduce HIV incidence.15  
Antiretroviral therapy (ART) is the primary means for reducing HIV related mortality and 
is a key biomedical component of the CHP initiatives. Since ART was introduced in Sub-Saharan 
Africa in 2004 through the United States Presidents Emergency Plan for AIDS relief (PEPFAR) it 
has resulted in improved quality of life for persons living with HIV and substantial reduction in 
population-level HIV associated mortality.16 While prior observational research strongly suggested 
ART reduced HIV transmission,17-19 the role of ART in HIV prevention was demonstrated 
definitively in the landmark HPTN 052 randomized trial carried out in sero-discordant couples in 
13 sites in Africa, Latin America, South Asia and North America.20 Results from the trial 
demonstrated a 93% relative reduction in HIV transmission to the uninfected partner with early 
initiation of ART.20 
Data from randomized control trials in the United States and Europe that daily pre-exposure 
prophylaxis (PreP) with oral ART also significantly reduces HIV acquisition.21,22 PreP has been 
touted as pivotal for HIV prevention particularly in key populations where early HIV infection is 
an important driver of transmission (e.g. MSM) 23 and among persons who may be vulnerable to 
HIV infection (e.g. young women in SSA).24 However, uncertainty about the population-level 
effectiveness of PreP remains particularly in sub-Saharan Africa, where low adherence to PreP 
regimens in clinical trials have resulted in significantly reduced efficacy compared to sites with 
high adherence elsewhere.21,25 
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ART is also effective for preventing mother to child transmission contributing to 
significant decline in pediatric infections in the SSA region. In the early 2000s with aid from the 
US government, countries in Sub-Saharan Africa started national programs which offered 
screening and treatment to HIV to pregnant women and their household.26 In 2013, the World 
Health Organization (WHO) recommended option B+, the lifelong use of ART in pregnant and 
breast feeding women who are HIV positive regardless of their CD4 viral count.15,26 ART therapy 
given to breast feeding mother and their infants have also been shown to reduce HIV transmission 
from an infected mother.27  
VMMC is a cornerstone biomedical prevention intervention in CHP programs.15Pivotal 
randomized trial in Rakai, Uganda, Orange Farm in South Africa and Kisumu, Kenya showed 
approximately 50% reductions in HIV incidence in circumcised men compared to uncircumcised 
men with similar behavioral risk factors.28-30 Medical male circumcision is particularly crucial in 
prevention strategies of settings of moderately high HIV prevalence with low circumcision rates.15 
Non-surgical male circumcision devices may be important in increasing the uptake of MMC. 
Several of these devices are undergoing regulatory assessments.15 
In summary, ART and VMMC together with behavioral change interventions (e.g. testing, 
counselling and condom promotion) are the bedrock of HIV prevention in SSA.15,31 Modelling 
studies have shown that concurrent use of these approaches could reverse the current epidemic, but 
only at high coverage levels.15,32,33 Rapid and sustained decline in infection rates in SSA will require 
global investments to scale up testing, treatment and prevention programs.16 Additionally, global 
and national commitment to ending the epidemic34 through leadership, sustained local investments 
and partnerships, as well as policies that promote health seeking behaviors and human rights for 
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1.3. HIV/AIDS in Uganda  
 
Uganda, a country in Central East Africa, is considered one of the earliest epicenters of the 
HIV/AIDS epidemic in Sub-Saharan Africa.4,35 The first cases of HIV in Eastern Africa were 
identified in a fishing village on Lake Victoria in Rakai District, Uganda in 1982.4 It was originally 
referred to as “Slim” disease- due to the muscle wasting now associated with late stage HIV/AIDS 
infection.4  
The HIV virus rapidly spread from the rural lake communities through trading routes to 
commercial centers and from there to rural inland communities. Initial prevalence in pregnant 
women peaked at ~ 30% in 1992 when it was estimated that 18% of the overall population was 
infected with HIV/AIDS and declined by 54% to a prevalence of 7.2% in 2012.36  By 1995 
approximately 90% of men and women in Uganda had known someone who died from AIDS.36 
Thus, the country initiated a comprehensive response to the epidemic including community based 
reporting of HIV-related deaths, mandatory education for men and women, prevention messages 
focused on abstinence, faithfulness in marriage and condom use with non-marital partners (ABC 
prevention).34,36-38  By 2001 HIV prevalence had declined to significantly across age groups, 
particularly in the younger age groups,36,37 however the main reasons for the decline observed has 
been subject to numerous debates.36-39 
The modern HIV epidemic in Uganda is characterized by substantial variation in HIV burden 
by geography and demography, with higher infection rates observed among women, Lake Victoria 
fishing communities,40 female sex workers and mobile populations.41For example, fisherfolk have 
a 42% HIV prevalence compared to a prevalence of 17% in trading communities and 14% in 
agrarian communities.41 HIV incidence is also higher among fisherfolk, 6.04 per 100 person years 
in the fishing communities compared to 0.56 per 100 person years in the general population.42 
Primary individual-level risk factors for HIV acquisition identified in Uganda are high risk sexual 
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behaviors (e.g. early sexual debut, multiple sexual relationships, transactional sex, lack of condom 
use)39,43-45 Alcohol use, presence of sexually transmitted infections, and lack of male circumcision 
has also been implicated.44,45 Societal factors also increase risk for HIV. Social drivers include low 
education, poverty, limited access and demand for antenatal care and delivery services and low use 
of ART in HIV positive persons.40 
 
1.4. HIV in Rakai, Uganda  
 
Rakai District (area ~2200 km2, population ~518 000) is a mostly rural district in South-Central 
Uganda.46 The district is bordered to the south by Tanzania and to the east by Lake Victoria. The 
capital city of Uganda is northeast of Rakai District by about 150km (Figure 1). The Rakai region 
has two main highways, Masaka road which connects Kampala to Tanzania and the Trans-African 
Highway which connects Kampala to the Democratic Republic of Congo.41  Since the discovery of 
the first AIDS cases in the region,4 HIV prevalence in the district remains among the highest in the 
country and is estimated to be at ~13%.47  
A recent study on HIV transmission patterns in Rakai’s agrarian and trading communities 
showed limited spatial clustering of HIV cases outside of households, multiple circulating HIV 
viruses within communities, and a significant proportion of incidence resulting from extra-
community partnerships were observed.35 Intra-household HIV accounted for approximately 39% 
of new incident cases in Rakai.35 Although intra-household transmission was common, more than 
half of the household introductions were due to partnerships outside the community.35 Viral 
introductions from extra-community partnerships presumably mediated by migration and short-
term mobility, are major sources of HIV incidence in Rakai.  
Preliminary data show that men from high-risk fishing communities around Lake Victoria 
outside the RCCS target area frequently travel to RCCS communities.35 The high incidence of HIV 
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observed in young women in the study was thought to be due to the extra-community partnership 
they maintained with these men.35 
 
 Figure 1. Map of the Rakai Region (taken from Chang et al, Lancet HIV, 2016) 
 
 
In 2004, under the United States President’s Emergency Plan for AIDS relief and the 
Global Fund for AIDS, Tuberculosis and Malaria, antiretroviral therapies were introduced into 
Uganda.48 The Rakai Health Sciences Program (RHSP), a non-governmental entity established in 
the district in 1987 to study the epidemiology of HIV. RHSP initially provided ART in mobile 
clinics in 16 catchment areas in the district.48,49 In 2003, Uganda switched from non-governmental 
provision of ART to provision of ART by the Ugandan Ministry of Health, known as “District-Led 
programming”. Currently, RHSP provides training and oversight to government clinics under the 
“District-Led Programming” initiative.50,51 
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All HIV positive individuals enrolled in care are offered CD4 tests and eligible individuals 
are offered ART. Their CD4 counts and viral loads are also monitored every 24 to 48 weeks.52 
Furthermore, all HIV positive persons are provided a basic care package of co-trimoxazole for 
prophylaxis against co-trimoxazole, bed nets for malaria prevention and clean water containers 
with hypochlorite for prevention of diarrheal diseases.53 The ministry of health in Uganda has 
adopted the 2013 WHO ART guidelines for ART initiation which starts HIV positive persons on 
ART if their CD4 cell count are less than or equal to 500 cells/mm3.52 A test and treat approach 
which recommends ART regardless of CD4 count has been adopted for key subgroups including: 
pregnant women, sero-discordant couples, fisherfolk and commercial sex workers.52 Per WHO and 
PEPFAR guidelines, a combination of one non-nucleoside reverse transcriptase inhibitor (NNRTI) 
and two nucleoside reverse transcriptase inhibitors (NRTI) are prescribed as first line therapy. 
Second line regimens typically include a boosted protease inhibitor with two drugs in the NRTI 
class.48,52 
Medical male circumcision is also a key component for HIV prevention in Uganda.54 The 
country launched an ambitious “Safe Male Circumcision” policy in 2010 to increase prevalence of 
MMC to 80% by 2015.54 In Rakai, prior to 2003, the prevalence of circumcision among non-
Muslim who made up 85% of the population was approximately 4%.54 Two trials conducted by the 
RHSP in 2003-2006 showed the preventive benefit of MMC in HIV acquisition28,55 and by the end 
of the trial, prevalence was up to 12%.54 With PEPFAR funding, the RHSP has provided free MMC 
services in the Rakai district.54 MMCs are provided free to consenting males aged 13 or older at a 
central facility, four satellite centers or mobile camps throughout Rakai.  
Although prevalence has remained stable, incidence has been reported to have declined 
from 1.17 per 100 person years in 1999 to 0.66 per 100 person years in 2016 due to scale-up of 
HIV prevention programs.56 Self-reported ART use increased from 12% to 69% between 2006 and 
2016 and by 2016, 61% of HIV positive men and 72% of HIV positive women reported ART use.56 
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Among all men, male circumcision coverage also significantly increased from 15% 1n 1999 to 59% 
in 2016, while coverage among non-Muslim men increased from 3.5% to 53% over the same 
period.56 
  The 90-90-90 target in viral load suppression has also been achieved in Rakai.56 By 2016, 
75% of HIV positive persons were virally suppressed compared with 42% in 2009.56  While HIV 
prevention programs have been successful and 90-90-90 targets achieved, incidence however 
remains above elimination levels.  
1.5. Barriers to HIV/AIDS Control in Uganda 
 
Despite widespread availability of numerous HIV preventive strategies in Uganda, barriers 
exist to the control of HIV in the region. It is estimated that only about 40% of people eligible for 
ART are currently being treated in the country.49 Studies show that linkage to care after HIV 
infection and retention to care are primary bottlenecks in the HIV care cascade, a series of 
benchmarks used to assess scale-up of ART and highlight opportunities for interventions.57 Cost of 
transportation to facilities which provide treatment and preventive services has been cited in some 
studies as a major constraint to service utilization.58-60 Competing needs, HIV related stigma, and 
personal belief about ART and HIV testing also barriers to HIV/AIDS control in Uganda.60,61 
  A fractured and underfunded health system also inhibits HIV control. Poor infrastructure, 
limited funds for medicines and other supplies, shortage of human resources in the public sector 
and negative interaction with health staff remain significant barriers to control.59,61 Discomfort and 
misconceptions about preventive services also contributes to service underutilization. For example, 
in Rakai, men quoted pain, fear about medical complication or infertility and association with Islam 
as a barrier to circumcision.62 
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1.6. Migration, Mobility and HIV/AIDS in Sub-Saharan Africa 
 
Migration is commonly defined as the movement of people in space; involving a change in 
usual place of residence63 Migration may also be defined based on movement in time; which 
differentiates circular migration (repetitive and temporary movement often involving short periods 
of time away) and definite migration (permanent movement away from an original place of 
residence with little or no indication of return).63 When migration occurs within national boundaries 
it is termed internal migration and an example of such as rural-urban migration common in many 
African countries.63 When movement occurs across international borders, it is termed international 
migration.63 In this thesis, we predominately assess internal migration and its impact on HIV 
incidence.   
Many studies have linked mobility and migration to the spread of HIV/AIDS in SSA (Table 
1). 64-69 Migration is considered one of the primary factors involved in driving HIV spread in cities 
in Africa.70 Following independence from colonial rule in the 1960s in many African countries, 
mass rural-urban migration drove population growth in urban centers in SSA.63 This migration 
resulted in rapid HIV spread within cities which is hypothesized to be partly a consequence of 
social disruption and massive urban unemployment.63 It is also hypothesized that circular migrants 
moving between urban to rural settlements and back served as conduits for the spread of the 
infection to rural populations where prevalence was relatively low in the initial stages of the 
epidemic.70 
Recent studies continue to report on associations between HIV and migration. 
Seroprevalence studies in Uganda, Tanzania and South Africa have all shown increased prevalence 
of HIV in migrants.66,71-73 Only one study has assessed HIV incidence among African migrants. 
The study, conducted in South Africa, showed a significantly increased risk of HIV acquisition 
with circulation migration regardless of distance travelled.74 
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    While prior studies have shown an association between migration and HIV, little is known 
about the causal pathways linking them. One hypothesis is that it is increased risky sexual behaviors 
in migrants leading to HIV infection. Indeed, a study in Rakai, Uganda found a higher prevalence 
of behavioral risk factors (e.g. multiple partnerships, inconsistent condom use) among adolescent 
migrants.75 Individual predisposition and changes in baseline behavior due to the process of 
migration itself have been proposed as two primary reasons for the increased behavioral risk in 
migrants.76  As early as 1958, Peterson theorized that migrants were inherently more adventurous 
or were willing to take more risks because many of them voluntarily moved to new social settings 
void of social support.77 However, research from Malawi suggests that where an individual 
migrates to may also contribute to increased HIV risk. In Malawi, prevalence of HIV is typically 
higher in urban centers increasing risk through heightened exposure rather than through individual-
level changes in sexual behaviors.64,76 Moving to environments more conducive to high risk 
behaviors may also result in behavioral disinhibition.64,76 
The extent to which social factors impact the association between migration and HIV has 
been understudied. Higher HIV prevalence among migrants may be due to limited social capital or 
discrimination in their new communities.78 Lack of social support and psychological factors 
associated with depression and isolation may also contribute to risk.78 Social networks of migrants 
are often composed of other migrants or their close and extended family.78 Those who migrate 
alone typically form close family-type relationship with other migrants.78 More limited social 
support and contacts within communities ultimately limits a migrant’s access to resources such as 
paid employment, health care services and HIV education programs.78 
Social networks formed during and after migration also impact HIV risk. Individuals who 
migrate on their own typically form multiple and concurrent sexual partnerships at higher rates 
compared to those who migrate with family.78 Separation from a regular partner or spouse is often 
cited as a contributory factor in the changes in sexual behaviors that occur in migrants.76 For 
example, commercial sex is common in occupations such as long distance truck driving which 
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involves long periods of time away from spouses.76  There is also evidence that sexual networks 
among migrants tend to be cyclic, involving small groups of connected individuals who are 
typically migrants, rather than dendritic.78 Cyclic network structures have been associated with 
increased transmission, however research on these network structures is limited.78 
There remain critical research gaps on migration and HIV. In general, these studies have been 
hampered by measuring the migration itself and by characterizing migrant populations who are 
difficult to enroll and follow in studies. There is also little understanding about why and how people 
migrate which has resulted in varied and broad definitions of migration and, in some cases, 
conflicting findings. Many studies have generally focused on rural-urban or urban- urban migration 
but the migration process is likely more nuanced falling on a continuum rather than within broad 
groupings. Prior research has also disproportionately focused on migrating men and their 
partners73,79 despite the increasing feminization of migration throughout SSA and some evidence 
that HIV risk associated with migration is concentrated among women.79-81 Lastly, most studies on 
HIV and migration are cross-sectional. Therefore, it is largely unknown whether HIV is a cause or 
consequence of migration. Notably, HIV-positive individuals have been shown to be more likely 















2.1. Study Objective  
 
The objective of the study was to assess the association between in-migration and the 
incidence of HIV in thirty communities Rakai District, Uganda. 
2.2. Study Hypothesis  
 
We hypothesized that HIV incidence is higher in individuals who recently moved into Rakai 
communities (in-migrants) compared to long-term residents with no migration history and that 
this risk is mediated by higher risk sexual behaviors in migrants. We also hypothesized that HIV 
risk associated with in-migration would decline following scale-up of combination HIV 
prevention. 
2.3. Conceptual Framework 
 
Figure 2 shows a conceptual framework linking migration and HIV acquisition. This 
framework adapted from Soskolne, is an example of an epidemiological model where in the 
primary risk factor acts as disrupter of the equilibrium between the agent, the host and the 
environment78.  In this case, migration causes personal and social network disequilibrium 
which increases risk of HIV exposure and acquisition 
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2.4. Study Setting, Population and Procedure 
 
The Rakai Community Cohort Study (RCCS) is a well characterized open, population 
based cohort established by the Rakai Health Sciences Program (RHSP) in 1994 to study the 
epidemiology and prevention of HIV.82 The RCCS originally carried out surveys in individuals 
aged 15-49 years in 56 communities in the district, however the number of communities 
surveyed has varied since the start of the study. This study uses data 30 communities 
continuously surveyed between April 1999 and January 2016 over 12 surveys. 
The RCCS holds an informational community mobilization event. A census is then done 
in all the households within the community to identify eligible persons. Global positioning 
(GPS) coordinates for each house are recorded and all residents of the household are 
enumerated by age, sex and duration of residence regardless of whether they were present or 
absent at the time of the census. Individuals who migrate into study communities (i.e. in-
migrants) and individuals who migrate out of study communities (i.e. out-migrants) are also 
recorded during census, and additional information on source and destination communities as 
well as reason for migration is obtained. After the census, eligible participants are enrolled at 
a central community location referred to as hubs. Other individuals who are eligible but not 
identified at the hubs are approached at their place of residence to request their participation. 
Return visits to the households are carried out up to two times if required to enroll all eligible 
individuals41.  
All eligible participants between the ages of 15 and 49 years who provide written consent 
are interviewed and information about time since arrival into a study community, 
demographics, sexual behaviors, antiretroviral therapy (ART) use, and male circumcision 
status is collected. Free HIV testing is provided after the interview. Results and counselling is 
offered after the test by on-site counsellors.41 To be included in the present study, participants 
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were required to be HIV-seronegative at baseline and contribute a least one follow-up visit 
allowing for no more than one missed visit. 
2.5. Laboratory Methods 
 
Before 2011, HIV tests were performed with a laboratory-based ELISA test with 
confirmation by Western blot.83 Subsequent tests have been performed with a validated parallel 
three test rapid HIV testing algorithm. All tests procedures followed the manufacturer’s 
guidelines.82 Concordant results are provided to participants with counselling and discordant 
results are confirmed by two enzyme immunoassays, EIA (Vironostika HIV-1, BioMerieux, 
and Recombigen, Cambridge Biotech). Where the EIA results are discordant, Western blots 
(GS HIV-1 Western Blot, Bio-Rad Laboratories, Redmond, WA, USA, BioMerieux-Vitek) or 
PCR are employed for confirmation.35 Participants provide whole blood through finger prick 
for the rapid HIV tests performed in the field and venous blood were collected in clot activator 
tubes for the lab based EIAs and Western blots.82 
2.6. Study Outcome  
 
The outcome of the study was incident HIV infection and was defined as a first HIV 
seropositive test result preceded by an HIV-seronegative test at the prior visit allowing for only 
one missed visit. HIV infection was assumed to occur at the mid-point of the visit interval.  
2.7. Primary Exposure and Confounders 
 
In-migration into an RCCS study community was our primary exposure variable. 
Specifically, in-migrants were defined as participants who moved into the study area with 
intention to stay. For each in-migrant and at all follow-up visits, we estimated their time since 
arrival in a community by calculating the difference between their data of arrival in the 
community (ascertained by self-report) to the mid-time point their current and prior study visit. 
To generate our exposure variable, we first broadly classified individuals as being either long-
  17 
 
term residents with no migration history or in-migrants. In-migrants were then stratified by 
how long they had resided in the community: 0-1 years, 1-2 years, 2-3 years, 4-5 years, and 
greater than five years. The migration exposure was included in our models as a time-varying 
categorical variable where residents with no migration history served as the reference group. 
Other exposure variables assessed included age, education, marital status religion, 
occupation and male circumcision status. Sexual behavior covariates included sex with a 
partner outside the community, number of sexual partners in past year, lifetime sexual partners, 
non-marital sexual partnerships, consistent condom use with a non-marital partner and alcohol 
use with sex.  
We also analyzed HIV incidence in three calendar time periods: 1999-2004, 2004-2011, 
2011-2015.  In the earliest these time periods, there was no antiretroviral therapy or voluntary 
medical male circumcision programs in Rakai. Antiretroviral therapy was introduced in Rakai 
in 2004 and subsequently scaled according to WHO guidelines. Male circumcision programs 
for HIV prevention were introduced in 2007. Our second calendar time included 2004-2011 
early during scale-up of these two biomedical interventions. The latest time period covers the 
most recent phase of combination HIV prevention scale-up in Rakai. Median ART and male 
circumcision coverage in the early combination HIV prevention period (2004-2011) was 20% 
and 31% respectively. In late CHP period, median ART coverage was 62% and median MC 
coverage was 56%. 
2.8. Statistical Analysis  
 
Baseline and sexual behavior characteristics of in-migrants and residents were compared using 
proportions for categorical and binary variables and median and interquartile ranges (IQR) for 
continuous variables. Statistically significant differences were assessed using chi-square tests for 
categorical and binary variables and Wilcoxon rank sum tests for continuous variables. 
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The unit of analysis was person-intervals of follow-up. Poisson regression models with 
generalized estimating equations (GEE) with an exchangeable correlation structure were used to 
estimate incidence rate ratio (IRR) of HIV and 95% confidence interval (95% CI) associated with 
migration. Multivariate analyses were first conducted only adjusting for demographics and calendar 
time. In a separate multivariate analysis, we hypothesized were mediators of the association 
migration and HIV risk. Analyses were also stratified by gender and by calendar time. In a sub-
analysis including only migrants, place of origin and distance travelled and reason for movement 
were assessed as risk factors for HIV acquisition.  
Lastly, a sensitivity analysis was performed to account for loss to follow up and selection bias 
using inverse probability survey weights.  Inverse probability weighting was implemented using 
methods previously described by Cole et al84. Briefly, models for survey participation and 
censoring were specified separately. Each person-visit was treated as an observation in the models 
which included the time-fixed and time-varying variables specified in the table above. Our model 
of survey participation included variables collected at time of census (age, gender and community 
of residence) whereas the censoring model included demographic and sexual behavioral variables 
collected at census and time of survey. The denominator of the weights was a logistic regression 
model for the probability of contributing person-time to the incidence cohort which was defined as 
the joint probability of participating in the survey and of being observed at the following survey. 
The numerator was the joint probability of the marginal distributions for participation and 
censoring. Weighted incidence rate ratios were estimated using Poisson regression assuming 
independence between individual participant observations conditional on observed covariates. 
2.9. Ethical Consideration 
 
All study participants provided written informed consent at baseline and follow-up visits using 
institutional review board approved forms. This study was reviewed and approved by the Ugandan 
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Virus Research Institute Security and Ethics Committee and the Western institutional review board 
(Protocol #20031318). This analysis was exempt from the Johns Hopkins Bloomberg School of 
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3. RESULTS  
 
3.1. Baseline demographics of the study population 
 
There were 26,995 individuals were eligible for participation of which 16,165 individuals 
contributed two or more visits and were included in the analysis. 55% (n=8789) were women and 
28% (n=4529) were classified as in-migrants. Participants contributed 69,231 person-visits at 
which 851 incident HIV events were identified (n=357 in men; n=492 in women).  
Demographic characteristics of participants at baseline are shown in Table 2. The median 
age was 22 years for both in-migrant and resident women while in-migrant men were slightly older 
than resident men (26 vs. 21 years in residents).  Among women, 57.1% (1768/3099) of in-migrants 
were in a monogamous marriage compared to 38.3% (2178/5690) of residents. In-migrant men 
(44%, 634/1430) were also more likely to be married compared to resident men (33%, 1974/5946).  
Majority of the participants regardless of migration status had a primary education; however, a 
higher proportion of in-migrants had technical or university education: 10% (313/3099) in migrant 
women and 16% (233/1430) in migrant men compared to 5% (269/5690) and 6% (338/5946) in 
resident women and men respectively. Agricultural work was the most common primary 
occupation among migrant women and men (41% among in-migrants vs. 46% among residents). 
Migrant and resident men reported administrative work as their most common primary occupation 
(28% among in-migrants vs. 39% among residents). Among men, male circumcision was slightly 
higher among in-migrants (25%, 356/1430) than in residents (18%, 1096/5946). All demographic 
differences were statistically significant.  
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3.2. Sexual behaviors by migration status  
 
Selected sexual behaviors of the in-migrants and residents are shown in Table 3. Overall, in-
migrants of both genders had somewhat higher levels HIV-related risk behaviors. While there was 
no statistically significant difference in non-marital partnership between migrant and resident 
women, in-migrant men were significantly more likely to report non-marital partnerships (57%, 
815/1430 vs. 47%, 791/ 5946; p= < 0.0001). Among those who reported non-marital partnerships, 
in-migrants of both genders were less likely to consistently use condoms (24% vs. 28% in women, 
p=0.029; 39% vs. 42% in men, p=0.015). Sex with partners outside the community was more 
common among migrants of both genders. Among women, 23% of in-migrants (715/3099) reported 
having sexual relationships with partners outside the community compared to 15% of residents 
(859/5690) (p= <0.0001). Among men, 39% (558/1430) of in-migrants reported sex with partners 
outside the community compared to 25% (1480/5946) of resident men (p= <0.0001). 
In-migrant men also tended to report more sexual partners in the past year compared to 
residents. For example, 34% of migrant men (485/1430) reported having 2-3 sexual partners 
compared to 24% (1444/5946) of resident men (p= <0.0001). Migrants of both genders also 
reported more lifetime sexual partners. Among men, 25% (359/1430) of in-migrants reported 
greater than five lifetime partners compared to 18% (1074/5946) residents (p= < 0.0001). Similarly, 
55% (1711/3099) of in-migrant women reported 2-3 partners compared to only 40% (2254/5690) 
of resident women (p= < 0.0001).  
3.3. HIV Incidence among in-migrants and residents  
 
A total of 849 HIV incident events occurred over 93,437 person years of follow-up, of which 
29% (n=243) occurred among in-migrants. HIV incidence rates and incidence rate ratios 
comparing migrants by time since arrival in the community to residents with no migration history 
is shown in Table 4. HIV incidence was higher among in-migrants compared to residents 
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regardless of gender. HIV incidence among women who migrated in the prior year was 2.19/100 
person-years (py) compared to 0.91/100 py in resident women (IRR = 2.00, 95% CI: 1.02-3.89). 
Risk remained elevated after adjustment with demographics adjIRRdem = 1.73, 95% CI: 0.90-3.37) 
but not with adjustment for demographics and sexual behaviors (adjIRRdem+ sex= 0.58, 95% CI: 
0.16-2.19).  Female HIV incidence between 1-2 years after migration was also significantly higher 
at 1.85/100 py (IRR = 2.12, 95% CI: 1.61-2.80). This risk persisted after both adjustment for 
demographics and sexual behaviors (adjIRRdem= 1.83, 95% CI: 1.36-2.46; adjIRRdem+ sex= 2.53, 
95% CI: 1.68-3.79). After two years of living in the community, HIV risk among migrant women 
was similar to long-term female residents. We also found statistically significant elevated HIV 
risk in the first two years following migration among men. Specifically, HIV incidence was 1.86 
per 100 py among men who had migrated into the community in the last year (IRR = 2.01, 95% 
CI: 0.49-8.21), 1.41 per 100 py among men who had migrated 1-2 years  prior (IRR = 1.81, 95% 
CI: 1.13-2.89), and 0.79 per 100 py among resident men. Risk also declined among men after 
these first two years.  
Because elevated HIV risk was largely concentrated in the first two years following the 
migration event, we next simplified our migration exposure into three categories: residents with no 
migration history, recent in-migrants (arrived <2 years), and non-recent migrants (> 2 years since 
arrival). In this more parsimonious analysis, HIV risk was significantly increased in the first two 
years after adjustment for demographics and sexual behaviors in both genders and in the full 
population (Table 5). Overall, HIV incidence was two-fold higher in recent migrants compared to 
residents (adjIRRdem+ sex= 2.02, 95% CI: 1.47-3.79). Sensitivity analyses with inverse probability 
weights did not change these inferences (Table 6).  
To assess the effect of combination HIV prevention (CHP) scale-up on HIV incidence in 
migrants and non-migrants, we further stratified our analysis by calendar period (Table 7). We find 
that while HIV incidence substantially declined in resident and non-recent migrants over time, HIV 
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incidence remained persistently high among recent migrant men and women. In the latest calendar 
period (2011-2015) with high levels of CHP coverage, HIV incidence was 1.76/100 py in recent 
migrant women and 1.45/100 py in recent migrant men compared to 0.61/100 pys and 0.48/100 pys 
in resident women and men, respectively. While HIV incidence declined by 42% and 56% in 
resident women and men, there were no significant HIV incidence declines among recent migrants.  
 
3.4. Risk of HIV among in-migrants  
 
The characteristics of in-migrants based on their reasons for moving to Rakai and their place 
of origin are shown of Table 8.  Among women, movement to live with a friend/ relative and 
movement due to a new marriage or consensual relationship were the most common reasons for 
migration (37.0% and 36.2% respectively). In contrast, men most commonly reported migrating 
for work (44.4%) or to start a new household (28.7%).  Most migration was local with largest 
numbers of migrants moving between communities within the district accounting (46% and 51% 
of migration events in men and women, respectively). Common places of origin outside Rakai 
included the neighboring Masaka District and the capital city, Kampala.  Overall, more than half 
of migrants were moving from communities <30 kilometers away.  
HIV incidence rates by reason for migration, place of origin, and distance traveled are shown 
in Table 9 stratified by gender. HIV incidence was highest among women moving to start a new 
household and men who were newly married.  There were no trends in risk for HIV by distance 
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4. DISCUSSION 
In this longitudinal population-based study, we find that in-migrants have higher HIV incidence 
and higher prevalence of high risk sexual behaviors compared to community residents with no 
migration history. We also show that elevated HIV risk associated with migration is highest in first 
two years following migration event and declines thereafter. Critically, we find that despite 
significant HIV incidence declines in residents with scale-up of combination HIV prevention, HIV 
incidence has remained persistently high in recent migrants. To our knowledge this is the first study 
to use longitudinal-based population based data to assess the time at which migrants are at highest 
risk for HIV acquisition following migration. 
In our study population, more women were classified as migrants than men, a finding which 
likely reflects the increasing feminization of migration observed throughout SSA.79,80 It is 
hypothesized that the higher proportions of migrating African women may be due to women 
seeking economic independence or increased familial responsibilities independent of male 
partners.75 However, we found that migrants were more likely to be married compared to residents 
and women were most likely to move because of marriage. Our results also show migrant men were 
slightly older than residents which is inconsistent with prior studies reporting that mobile men are 
typically younger and unmarried. Notably, women have restricted access to land and assets in 
Uganda resulting in financial dependence that makes them more likely to move to the residence of 
their male partners.85 
We observed significantly higher levels of high risk sexual behaviors among migrants 
compared to residents which is consistent with previous studies showing migrants tend to have 
higher HIV risk profiles.66-68,81 Both male and female in-migrants reported more sexual activity, 
greater proportions of lifetime sexual partners, non-marital partnerships and sex with partners 
outside the community. They were also less likely to report consistent condom use with a non-
  25 
 
marital partner. An earlier study from Rakai found that sex with extra-community partners was 
associated with substantially increased risk among women.35 
Taken together, our results support the hypothesis that in-migrants have a higher risk of HIV 
acquisition. Notably, HIV risk was highest in the first two years following the migration event 
suggesting that interventions targeted to migrants would need to intervene early in the settlement 
process. This higher HIV risk among recent migrants may be due in part to higher levels of sexual 
risk behaviors during the migration process, but migration remained associated with HIV 
acquisition even after adjustment for sexual behaviors suggesting causal pathways independent of 
individual level behaviors. Similar findings were observed in a cross-sectional study in Tanzania 
where the odds of HIV infection were ~ 2.4 in recent male and female in-migrants compared to 
residents.72  The study also found an inverse association between risk behaviors and time after in-
migration which we did not examine here.  
Of key importance to HIV control, we found that HIV incidence has remained high in migrants 
despite substantial scale-up of combination HIV prevention. While HIV incidence has declined 
substantially among residents, incidence has remained high among recent in-migrants with minimal 
evidence of decline. Our results suggest that ongoing HIV prevention programs have had minimal 
impacts on migrant populations.  
Prior research suggests that female migrants are most at risk for HIV.76,80,81 This trend was also 
observed in this study with female in-migrants having consistently statistically significant increased 
HIV incidence compared to men across CHP scale-up period. The increased risk behaviors also 
observed among female in-migrants suggests that women are in part putting themselves at risk 
through their own behaviors.81 The structural and economic barriers women face may compel them 
to engage in these risky behaviors for survival such as commercial sex work.76,86 
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The earliest years following migration are associated increased vulnerability, particularly 
amongst young people. The immediate period after migration is associated with increased 
instability, detachment from family, friends, and previous community and changing social norms. 
This social disruption likely promotes HIV risk behaviors such as multiple partnerships, casual 
relationships and inconsistent condom use as observed in this study and, consequently, increased 
risk of HIV acquisition. Unfortunately, prior research suggests that linking migrants to HIV 
treatment and prevention programs is challenging.87 Migrants often learn about their HIV status 
long after infection,87,88reducing the likelihood of early treatment initiation and suppression. 
Reluctance of HIV-positive migrants to link to and remain in care has been linked to stigma, 
frequent and circular migration, unfamiliarity with new environment and lack of knowledge about 
the new health systems.87 
There is a need to identify recent migrants and link them into health services. Programmatic 
tools to effectively identify new migrants in communities are currently lacking. The use of mobile 
technology has previously been suggested.89,90 Community health workers who travel outside 
clinics to locate patients in the community have been employed in some settings to aid retention in 
care91 and may also be useful to in engaging migrant populations. However, special ethical 
considerations may need to be made for programs targeted to migrants. Migration is a diverse 
process that is sometimes circular, international or internal and may be intentional or forced. In 
particular, forced migrants may have special need that would need to be addressed in programmatic 
design. Cultural and language barriers facing migrants in their new communities should also be 
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4.1. Strengths and Limitations 
 
There are important limitations to this study.  Demographic and sexual behavior data were self- 
reported and could have been subject to social desirability bias.  Participation and follow-up rates 
may have resulted in selection bias however; the analyzed sample size was still large and results 
from sensitivity analysis using inverse probability weights did not change the inference drawn from 
the study. We did not assess the association between circular migration and HIV incidence or urban-
rural migration patterns. Based on the conceptual framework used in this study, the sexual 
behaviors in this study could have been mediators of the association of migration and HIV and 
adjusting for them could have attenuated some of the effect size, however, the magnitude of the 
effect remained similar after adjustment. There is also the potential for residual or unmeasured 
confounding. Finally, the external validity of this study should be considered before generalizing 
the findings to other populations outside Rakai. Unique characteristics of Rakai may limit 
extrapolating this finding to other studies. However, RCCS demographic and behavioral data are 
consistent with other surveys carried out in the region.92 
 Apart from the novelty of our study in measuring incidence following migration in a mobile 
population, the use of a well characterized population-based longitudinal data allowed us to 
effectively characterize the migration exposure.  
4.2. Conclusion 
 
In conclusion, we find that the first two years following migration is associated with 
substantially increased HIV risk.  HIV incidence remains high among in-migrants compared to 
residents even with scale-up of HIV prevention programs in Rakai. Active surveillance, 
identification and retention of migrant population in HIV prevention and treatment programs is 
needed to reduce the burden of HIV in Rakai.  




Table 1: Summary of selected publications linking migration and/or mobility and HIV in Sub-Saharan Africa 
 
Authors [REF] Location Study Type  Incidence/Prevalence 
Measured  
Main Findings  
Dobra et al 74 South Africa  Population-based cohort 
study  
Incidence Increased risk of HIV 
acquisition with larger 
average distance travelled 
and increased time outside 
the study area. 
Anglewicz et al65 Malawi  Population-based cohort 
study 
Prevalence (Odds of 
migration given HIV 
status) 
HIV positive individuals 
were more likely to 
migrate out of rural areas 
to urban areas, however 
HIV positive Individuals 
were also more likely to 
return to their village of 
origin 
Schuyler et al66,75  Uganda  Population-based cohort 
study  
Prevalence  Mobile youths were more 
likely to report behavioral 
risk factors for HIV.  
Kishamawe et al66  Tanzania  Longitudinal cohort study  Prevalence  Increased sexual risk 
behavior and HIV 
prevalence in mobile 
individuals and the 
partners who remained 
behind 
Lagarde et al67 Guinea Bissau/ Senegal  Cross-sectional survey Prevalence  Short term mobility 
associated with increased 
risk behaviors and 
increased HIV prevalence.  
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Nunn et al71  Uganda  Longitudinal cohort study  Prevalence  Change of residence 
associated with increased 
risk of HIV-1 infection 
likely due to increased 
risky sexual behavior 
among those who move 
Mmbaga et al72 Tanzania  Cross-sectional survey  Prevalence  HIV prevalence was 
higher in migrants, but 
higher in recent in-
migrants. The odds of 
HIV infection were also 
higher in recent in-
migrants. Risk behaviors 
was inversely related to 
years since in in-
migration. 
Lurie et al73  South Africa  Cross-sectional survey Prevalence Migration was a 
significant independent 
risk factor for HIV 
infection. 
Lydie et al68 Cameroon  Cross-sectional survey  Prevalence Mobile men reported 
riskier sexual behaviors 
and HIV infection 
increased with time away 
from home 
Coffee et al69  South Africa  Modelling based on 
population-based cohort 
study data  
Prediction model of HIV 
prevalence 
Migration coupled with 
increased sexual risk 
behavior among migrant 
men would increase the 
prevalence of HIV among 
the migrants’ female 
partners 
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Camlin et al81 South Africa  Cross sectional study Prevalence (Odds of HIV 
infection) 
Female migrants had 
higher odds of HIV 
infection compared to 
male and female non-
migrants. Each additional 
lifetime sexual partner 
was associated with a 22% 
increase in the odds of 
HIV infections for female 
migrants. The association 
was not significant in 
migrant men.  















































































































































Table 2:  Demographic characteristics at baseline or first visit following in-migration 




















































































































  33 
 






























Sex in the past year with a partner 
residing outside the community 







































































Greater than 5 
Can’t Remember/Unknown 














































Table 3:  Sexual risk behaviors at baseline or first visit following in-migration 
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# In participants who reported being sexually active 
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Table 4: Model A, gender stratified crude and adjusted HIV incidence rate and incidence rate ratio by time since in-migration 
 
  Women    
Migrant category No of Events/ py*at 
risk 
Incidence rate per 100 py 
(95%CI) 






Residents 320/35269.15 0.91(0.81-1.01) REF REF REF 
In-migrants, 0-1 year 9/410.63 2.19(1.14-4.21) 2.00(1.02-3.89) 1.73(0.90-3.37) 0.58(0.16-2.19) 
In-migrants, 1-2 
years 
61/3301.00 1.85(1.44-2.38) 2.12(1.61-2.80) 1.83(1.36-2.46) 2.53(1.68-3.79) 
In-migrants, 2-3 
years 
21/1984.58 1.06(0.69-1.62) 0.98(0.62-1.54) 0.90(0.56-1.43) 1.17(0.59-2.29) 
In-migrants, 3-4 
years 
20/2112.48 0.94(0.61-1.47) 1.28(0.81-2.01) 1.13(0.71-1.79) 1.42(0.73-2.74) 
In-migrants, 4-5 
years 
10/1345.78 0.74(0.40-1.38) 0.86(0.45-1.62) 0.80(0.42-1.53) 0.99(0.35-2.82) 
In-migrants, > 5 
years 
51/6342.38 0.80(0.61-1.06) 0.91(0.67 -1.22) 0.95 (0.69-1.31) 0.82(0.47-1.43) 
  
Men 
   
Migrant category 
     
Residents 286/36157.90 0.79(0.70-0.89) REF REF REF 
In-migrants, 0-1 year 2/107.63 1.86(0.46-7.42) 2.01(0.49-8.21) 2.03(0.49-8.45) 3.22(0.73-14.1) 
In-migrants, 1-2 
years 
19/1349.83 1.41(0.90-2.21) 1.81(1.13-2.89) 1.77(1.11-2.84) 1.81(0.99-3.29) 
In-migrants, 2-3 
years 
10/917.05 1.09(0.59-2.03) 1.31(0.69-2.48) 1.17(0.61-2.25) 1.66(0.82-3.35) 
In-migrants, 3-4 
years 
7/874.90 0.80(0.38-1.68) 1.30(0.61-2.76) 1.19(0.55-2.56) 0.97(0.34-2.74) 
In-migrants, 4-5 
years 
6/666.51 0.90(0.40-2.00) 1.34(0.59-3.03) 1.30(0.57-2.97) 1.37(0.49-3.81) 
In-migrants, > 5 
years 
27/2596.79 1.03(0.71-1.52) 1.35(0.90-2.02) 1.44(0.95-2.21) 1.28(0.70-2.35) 
  
 
   




     
Residents 606/71427.05 0.85(0.78-0.92) REF REF REF 
In-migrants, 0-1 year 11/518.27 2.12(1.18-3.83) 2.09(1.14-3.81) 1.81(0.99-3.30) 0.97(0.36-2.55) 
In-migrants, 1-2 
years 
80/4650.84 1.72(1.38-2.14) 2.10(1.66-2.65) 1.83(1.43-2.35) 2.22(1.61-3.06) 
In-migrants, 2-3 
years 
31/2901.63 1.07(0.75-1.52) 1.10(0.76-1.59) 0.99(0.67-1.45) 1.30(0.80-2.12) 
In-migrants, 3-4 
years 
27/2987.38 0.90(0.62-1.32) 1.32(0.90-1.95) 1.14(0.77-1.69) 1.20(0.70-2.09) 
In-migrants, 4-5 
years 
16/2012.30 0.80(0.49-1.30) 1.02(0.62-1.69) 0.91(0.55-1.52) 1.07(0.51-2.22) 
In-migrants, > 5 
years 
78/8939.17 0.87(0.70-1.09) 1.05(0.83-1.34) 1.04(0.81-1.35) 0.91(0.60-1.36) 
*person-years 
++ Adjusted for demographics alone  
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Table 5:  Model B, gender stratified crude and adjusted HIV incidence and incidence rate ratio by time since in-migration 
   
Women 
   
Migrant category No of Events/ py* at risk Incidence rate per 100 py 
(95%CI) 






Residents 320/35269.15 0.91(0.81-1.01) REF REF REF 
In-migrant, 0-2 years 70/3711.64 1.89(1.49-2.38) 2.10(1.62-2.73) 1.81(1.37-2.41) 2.15(1.44-3.22) 




   
Residents 286/36157.90 0.79(0.70-0.89) REF REF REF 
In-migrant, 0-2 years 21/1457.47 1.44(0.94-2.21) 1.83(1.17-2.86) 1.79(1.14-2.82) 1.92(1.09-3.39) ^ 




   
Resident 606/71427.05 0.85(0.78-0.92) REF REF REF 
0-2 years 91/5169.11 1.76(1.44-2.16) 2.10(1.68-2.62) 1.83(1.45-2.32) 2.02 (1.47-2.77) 
In-migrants, > 2 Years 152/16840.47 0.90(0.77-1.06) 1.10(0.92-1.32) 1.03(0.85-1.26) 1.07(0.81-1.43) 
*person-years 
++ Adjusted for demographics alone  
**Adjusted for demographics and sexual behaviors  
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Table 9:   Sensitivity analysis, gender stratified crude and adjusted incidence rate ratio of HIV by time since in-migration 
using inverse probability survey weights                                                                                                                                                     
Migrant category, Women Crude IRR (95% CI) Adjusted IRR++ (95% CI) Adjusted IRR** (95% CI) 
Residents  REF REF REF 
In-migrants, 0-2 years 2.79(1.91-4.07) 2.24(1.50-3.35) 2.11(1.40-3.18) 
In-migrants, > 2 years  1.25(0.88-1.78) 1.07(0.73-1.57) 1.00(0.67-1.48)     
Migrant category, Men 
   
Residents REF REF REF 
In-migrants, 0-2 years 1.83(1.06-3.14) 1.81(1.03-3.17) 1.70(0.96-3.05) 
In-migrants, > 2 years  1.51(1.01-2.26) 1.31(0.86-2.00) 1.34(0.87-2.06)     
Migrant category, All participants  
   
Residents REF REF REF 
In-migrants, 0-2 years 2.58(1.90-3.49) 1.99(1.44-2.74) 1.90(1.38-2.63) 
In-migrants, > 2 years  1.45(1.12-1.90) 1.09(0.82-1.46) 1.06(0.79-1.42) 
++ Adjusted for demographics alone  
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Table 7: Adjusted IRR of HIV by time since in-migration, stratified by gender and combination HIV (CHP) scale-up period 
 Women Men 










In-migrants, 0-2 years 
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Table 8: Gender stratified in-migration characteristics 
In-migration Characteristics  Women Men 
Reasons for In-migration   
Newly Married/New consensual 1122(36.2) 24(1.7) 
Work 620(20.0) 635(44.4) 
Started New Household 180(5.8) 410(28.7) 
Living with relatives/friends 1145(37.0) 276(19.3) 
Other reasons1 32 (1.0) 85 (5.9) 
In-migration Origin  
  
Rakai District  1588 (51.2) 651 (45.5) 
 Kasasa 164 (10.3) 70 (10.8) 
 Kyotera 336 (21.2) 131 (20.1) 
 Lwanda 219 (13.8) 95 (14.6) 
 Kakuuto 214 (13.5) 95 (14.6) 
 Kabira 138 (8.70) 58 (8.9) 
 Kalisizo 186 (11.7) 58 (8.9) 
 Kitumba 116 (7.3) 61 (9.4) 
 Kyanamukaaka 85 (5.4) 32 (4.9) 
 Kyebe 77 (4.9) 31 (4.8) 
 Lyantonde 53 (3.3) 20 (3.1) 
Masaka District  178 (5.7) 82 (5.9) 
Elsewhere in Rakai  520 (16.7) 189 (13.2) 
Kampala  187 (6.0) 136 (9.5) 
Elsewhere in Uganda  295 (9.5) 136 (9.5) 
Outside Uganda  42(1.4) 17 (1.2) 
Unknown  226 (7.3) 182 (12.7) 
Missing  63 (2.0) 34 (2.4) 
Distance from In-migration Origin   
0-5 Kilometers  651 (21.0) 317(22.2) 
5-15 Kilometers  844 (27.2) 283(19.8) 
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15-30 Kilometers  606 (19.6) 227 (15.9) 
30-90 Kilometers  466 (15.0) 234(16.4) 
90-180 Kilometers  267 (8.6) 129 (9.0) 
Greater than 180 Kilometers  265 (8.6) 240 (16.8) 
   
Data are number (%) unless otherwise specified. Some percentages do not add to 100 because of rounding 
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Table 9: Gender stratified incidence rate of HIV by in-migration  
In-migration Characteristics  Incidence Rate/100 py* (95% CI) Incidence Rate/100 py (95% CI) 
Reasons for In-migration  Women Men 
Newly Married/New consensual relationship  1.06 (0.82-1.35) 2.20 (0.71-6.82) 
Work  1.14 (0.82-1.58) 0.97 (0.67-1.41) 
Started new household  2.00 (1.29 -3.10) 0.92 (0.60-1.42) 
Living with Relative/friend  0.94 (0.72 – 1.23) 1.28 (0.79 – 2.10) 
Other Reasons1 - 0.72 (0.23 – 2.22) 
In-migration Origin    
Rakai District  1.04 (0.88-1.24) 1.06 (0.78-1.46) 
Masaka District  1.43 (0.90-1.75) 1.15 (0.48-2.76) 
Elsewhere in Rakai  1.29 (0.95-1.75) 1.05 (0.52-2.10) 
Kampala 1.32 (0.81-2.17) 1.02 (0.42-2.44) 
Elsewhere in Uganda  0.77(0.47-1.26) 1.24 (0.59-2.61) 
Outside Uganda  0.35 (0.049-2.48) - 
Unknown 0.71 (0.43-1.17) 0.58 (0.24-1.39) 
Distance from In-migration Origin    
0-5 kilometers 1.06 (0.77-1.46) 1.46 (1.00-2.16) 
5-15 kilometers  0.99 (0.74-1.32) 0.92 (0.55-1.56) 
15-30 kilometers  1.05 (0.75-1.47) 0.77 (0.39-1.54) 
30-90 kilometers  1.33 (0.92-1.92) 1.01 (0.54-1.88) 
90-180 kilometers  1.46 (0.91-2.35) 1.03 (0.46-2.30) 
Greater than 180 kilometers  0.81 (0.45-1.46) 0.66 (0.31-1.38) 
*
person-years    
  1Other reasons include: Divorced/Separated, Education, Polygamous man travelling between household 
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